September 02, 2014
Pfizer Inc. on Friday defeated for the second time allegations that it greatly exaggerated the efficacy of its antidepressant Zoloft, when a federal judge in California ruled the proposed class action claims are time-barred and dismissed the suit with prejudice.
February 24, 2014
A California federal judge on Friday tossed a proposed class action accusing Pfizer Inc. of tricking consumers into overpaying for the antidepressant Zoloft by exaggerating its effectiveness, ruling that the suit is time-barred because the plaintiff stopped taking the drug in 2008.